基于竞争性酸阻塞剂和质子抑制剂的方案用于一线杆菌根除:一个网络元分析
Peter Malfertheiner1,2, Steven F Moss3, Patrick Daniele4
1Department of Gastroenterology, Hepatology and Infectious Diseases, Otto v. Guericke University, Magdeburg, Germany.
Gastro hep advances
|August 12, 2024
概括
与标准的质子抑制剂疗法相比,基于诺普拉桑的疗法提供了优越的Helicobacter pylori根除. 这项分析表明,诺普拉桑比基于PPI的三重疗法更有效,比比斯木斯四重疗法同等或更好.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 有效的酸性抑制对于 Helicobacter pylori (H. pylori) 根除至关重要.
- 标准治疗涉及质子抑制剂 (PPI) 与抗生素相结合.
- 沃诺普拉桑是一种与竞争的酸阻塞剂,比PPI提供更强大和更持久的酸抑制作用.
研究的目的:
- 为了比较基于vonoprazan的疗法与已批准的标准H. pylori根除方案的疗效.
- 分析来自北美和欧洲Phase 3 pHalconHP试验的新证据.
主要方法:
- 系统性文献评论和MEDLINE/Embase数据库的文献搜索发现了相关的研究.
- 贝叶斯网络元分析是在随机对照试验中进行的,比较治疗方法.
- 包括的研究报告了经验治疗的第一线H. pylori根除率.
主要成果:
- 分析了来自42项试验 (12,773名患者) 的23种治疗方案.
- 基于诺普拉赞的三重疗法显示了最高的相对疗效 (OR:2.73),并且72.1%的概率是最佳疗法.
- 基于诺普拉桑的疗法显示出比基于PPI的三重疗法更高的H. pylori根除几率,并且优于木亚酸盐四重疗法 (OR:1.60).
结论:
- 基于诺普拉桑的疗法代表了对H.pylori感染的新,全球有效的治疗方法.
- 与基于PPI的三重疗法相比,这些疗法具有更高的疗效.
- 疗效可比或更好,比比斯木斯四重疗法用于H. pylori根除.
更多相关视频
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
338
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
338
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
363
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
363
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
412
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
412
01:26Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
337
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
337
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
362
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
362